Clinical: sore throat, HA, drowsiness, fever, neck stiffness, photophobia , hemorrhagic skin rash with septicemia
H. influenza (infants, young children)
Listeria monocytogenes
E. coli, Group B strep
TB
Clinical: always focus of infx outside CNS, but 25% without signs/symptoms. Usually gradual onset, though occasionally rapid and presents like SAH
Treatment of Bacterial Meningitis
Community Acquired
Vanco (for resistant pneumococcus), plus
Ceftriaxone 2g or cefotaxime, or
Ampicillin (age > 50) +/- gentamicin for synergy (certainly add if bacteremia / sepsis) & monitor drug levels (peak and trough) & monitor for toxicity (ototoxicity, nephrotoxicity)
Dexamethasone 10mg IVq6h x4d
Rifampin prophy for close contacts of pt with meningococcal meningitis; cipro prophy for adult contacts?
Immunocompromised
Ceftriaxone 2g IV q12h or cefotaxime or cefepime (if pseudomonas risk); plus
Vanco; plus
Ampicillin 2.0g IV q4h
Steroids clearly indicated for Strep pneumo; some would give for all bacterial meningitis
Pen Allergy
Chloramphenicol (covers meningococcus, H. influenza, S. pneumo, E. coli
Duration of Treatment
Practice Guidelines for Bacterial Meningitis • CID 2004:39 (1 November) • 1281
Microorganism : Duration of therapy, days
Neisseria meningitidis : 7
Haemophilus influenzae : 7
Streptococcus pneumoniae : 10–14
Streptococcus agalactiae : 14–21
Aerobic gram-negative bacilli : 21
Listeria monocytogenes : 21
Viral Meningitis
Overview: The most common meningitis
Viruses
HSV, mumps, lyphocytic choriomeningitis, polio, coxsackie, echo, japanese encephalitis, eatern and western equine, louping ill, HIV
Dx: PCR
Generally speaking, benign course with complete recovery
Fungal Meningitis
Cryptococcus neoformans
Coccidioides immitis
Protozoal Meningitis
Naegleria
stagnant fresh water, inhaled --> meninges
healthy, non-immunosuppressed patient
Acanthamoeba spp.
cause chronic granulomatous amebic encephalitis
Encephalitis
Overview: Usually viral, though infectious agent often not identified. Brain parenchyma inflammed in encephalitis, as oppossed to the lining of the brain in meningitis.
Overview: look for predisposing factor (surgery, trauma, chronic osteomyelitis of adjacent bone, septic empbolism, chronic cerebral anoxia). Acute abscesses generally mixed oropharyngeal flora; chronic more typically TB or C. neoformans. If immunosuppressed, consider fungi, protozoa
Bacteroides, peptococcus or petostreptococcus, and Propionibacterium acnes
Fungi
aspergillus, candida spp.
Case Study
Chronic OM complicated by mastoiditis, meningitis, and bacteremia
DDx: acquired cholesteatoma, congenital cholesteatoma, granulation tissue without a cholesteatoma. Presence of any of these conditions may --> intracranial and extracranial complications with chronic OM. Compx: extradural abscess, subperiosteal abscess, meningitis, venous sinus thrombosis, thrombphlebitis --> brain abscess
cholesteatoma:: cystlike mass of squamous epithelial debris in the middle ear
acquired may result from chornic infx (& retraction of TM)
congenital may arises from epidermoid rest in developing middle ear
Tx: ABx, neurosurg consult
Neurosurg
sterotactic drainage of empyema
epidural abscess can be drained through burr hole
subdural empyema requires craniotomy
ventriculostomy or permanent shunt for hydrocephalus
Otologic Mgmt
R. mastoidectomy and decompression of sigmoid sinus to decresae infectious load and drain Bezold's abscess
anticoagulation for sigmoid sinus thrombus (only if it extends beyond sigmoid, or if neuro changes or persisent fever)
Hx: cough, fever, sputum production, dypsnea +/- pleurisy or GI symptoms
Physical exam: fever, tachypnea, rales, or evidence of consolidation
Site of care: if score 0-1, may treat as outpatient
Consciousness decreased
Urea, blood increased
Respiratory rate >30
Blood pressure < 90
65 (age)
Dx:
CXR
bacteria: consolidation
viral: b/l and interstitial
Dx tests for major pathogens
S. pneumo: BCx, sputum G stain and Cx, urine antigen assay
Legionella: urine Ag assay and Cx on selective media
C. pneumoniae: no tests; rare cause of CAP
M. pneumoniae: IgM, peds only
S. aureua, Moraxella catarrhalis, H. influenzae, other GNB: blod Cx, sputum G stain and Cx
Viral: PCR
Tx:
Outpatient
empiric:
Azithromycin (500mg PO d1, then 250mg d2-5 = Zpak); or
Clarithromycin 1g (XR) po daily or 500mg po BID x 7d
with comorbidity (COPD, DM, CHF, etc), or recent ABx
as above; or
Moxifloxacin 400mg po daily x 7d; or
Levofloxacin 750mg po daily x 5d
Hospitalized
Non-ICU
Empiric:
1. FQ alone
Moxifloxacin 400mg po/iv daily x 7-10d; or
Levofloxacin 750mg po/iv daily x 7-10d
2. Cephalosporin + macrolide
Ceftriaxone 1g IV q24hr OR Fefotaxime 1g iv q8hr + azithro 500mg IV/PO daily
Aspiration:
1. Clindamycin 600mg IV q8hr + FQ
2. Augmentin
3. Zosyn
Influenza with bacterial superinfection (S. pneumo > S. aureus > GAS)
Ceftraixone or cefotaxime +/- oseltamivir 75 mg po BID x 5 d
consider MRSA, add Vanc or Linezolid
If structural lung dz, consider covering for Pseudomonas
ICU, empiric
***
B. HAP
Pathogens
Staph. aureus (MRSA > MSSA)
G- bacilli: Klebsiella, Enterobacter, E. coli, Pseudomonas, S. maltophilia, Acietobacter spp., and others
Dreaded: KPC
Legionella spp.
Anaerobes (aspiration)
Viruses: influena, RSV, parainfluenza
Clinical
Symptoms > 48 hours after hospitalization
early: occurs w/in 4d hospitaliztion
Late-onset: > 4d, usually more resistant pathogens
Organisms you can IGNORE:
Staph epi
Eterococcus spp.
ALL G+ rods other than Nocardia and B. anthracis, Candida spp.
Biggest problems to treat: P. aeruginoas, Acinetobacter spp.
Diagnosis
Cx: blood, expectorated sputum, +/- BAL
Viral studies (influenza, RSV, etc.)
Legionella Ag
DDx: CHF, PE, drug fever, ARDS, inflammatory lung dz, malignancy
Tx:
EMPIRIC
knowledge of local antibiogram helpful
Risk of MDR pathogen: hospitalized > 4d, admitted from chronic care facility, ABx received w/in past 90 d, immunosuppression, high rates of ABx resistance in region or facility
Low Risk of MDR (early HAP)
Ceftriaxone 2 g IV
Levofloxacin 750mg IV/PO
Ciprofloxacin 400mg q8hr IV
Moxifloxacin 400mg q24hr IV
Amp/sulbactam 2gm IV q6h
Ertapenem 1gm IV q24hr
High Risk of MDR: empiric Tx should cover P. aeruginosa, other GNB (e.g. ESBLs, KPC producing Dklebsiella or other GNs, Acinetobacter, etc), S. aureus (MRSA)
Use (1) beta-lactam and (2) FQ or aminoglycoside and (3) vanc or linezolid